Related Experiment Video
Updated: Feb 6, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Comparative Study of Minimally Invasive with Open Surgical Staging Procedure for Endometrial Cancer: A
D Suresh Kumar1, S Navin Noushad1, Ajay Sharma1
1Tamil Nadu Government Multi Super Speciality Hospital, Chennai, Tamil Nadu India.
Minimally invasive surgical staging for endometrial cancer offers better survival rates and less morbidity than open surgery. This approach results in reduced blood loss and shorter hospital stays, demonstrating oncological safety.
Area of Science:
- Gynecologic Oncology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Endometrial cancer management involves surgical staging to determine extent and guide treatment.
- Traditional open surgical staging (laparotomy) is associated with significant morbidity.
- Minimally invasive surgical staging (laparoscopy/robotic) offers potential benefits but requires oncological validation.
Purpose of the Study:
- To compare oncological effectiveness, morbidity, and perioperative outcomes between minimally invasive and open surgical staging for endometrial cancer.
- To evaluate disease-free survival, operative time, blood loss, lymph node yield, and hospitalization duration.
- To assess the safety and efficacy of minimally invasive approaches in endometrial cancer management.
Main Methods:
- Retrospective analysis of 217 endometrial cancer patients treated between January 2015 and November 2024.
- Comparison of outcomes between open surgical staging (n=93) and minimally invasive surgical staging (n=124; 86 laparoscopic, 38 robotic).
- Statistical analysis using Fisher's exact test, Student's t-test, and Kaplan-Meier survival analysis (p≤0.05 significance).
Main Results:
- Minimally invasive surgery had shorter operative times (115 vs 136 min, p=0.009) and significantly less blood loss (60 vs 140 ml, p=0.007).
- Hospitalization was shorter for minimally invasive staging (4 vs 6 days, p=0.005), with no significant difference in lymph node retrieval (p=0.09).
- Disease-free survival at 3 years was higher in the minimally invasive group (95.2% vs 88.3%, p=0.003).
Conclusions:
- Minimally invasive surgical staging is oncologically safe and effective for endometrial cancer.
- It offers superior perioperative outcomes, including reduced blood loss and shorter hospital stays.
- This approach is associated with improved disease-free survival compared to open surgical staging.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Blind Procedures
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
What is an Experiment?
Cancers Originate from Somatic Mutations in a Single Cell
Bioavailability Study Design: Single Versus Multiple Dose Studies

